Home › Quitting Smoking › NCT06290869
Tobacco Education and Lung Health Study (TEAL)
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial (Tobacco Education and Lung Health Study)
Who can join
Ages 50 to 80 · All sexes
Full eligibility criteria
Inclusion Criteria: * eligible for a screening or diagnostic scan, * USPSTF eligibility criteria (50-80 years old and \>20-pack years); * currently smoking cigarettes (\>1 in the past 30 days); * English speaking; * able to provide meaningful consent. Exclusion Criteria: * prior lung cancer, * hearing impairment, * cognitive impairment, * household member already enrolled.
About the study
Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes.
Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.
What is being tested
- Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention (behavioral)
- E-Referral to the Tobacco Quitline (behavioral)
Sponsor: Georgetown University · Participants: 1,188 · Started: Feb 22, 2024
Contact the study team
- Kathryn L Taylor, PhD · Phone: 2022159402
Official record on ClinicalTrials.gov — NCT06290869
Locations in the U.S.
| District of Columbia | Georgetown University Medical Center, Washington D.C. |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.